Heartland Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.74M | Sell |
14,171
-8,728
| -38% | -$1.07M | 0.1% | 183 |
|
2025
Q1 | $2.32M | Sell |
22,899
-3,004
| -12% | -$304K | 0.13% | 174 |
|
2024
Q4 | $2.39M | Sell |
25,903
-559
| -2% | -$51.6K | 0.13% | 165 |
|
2024
Q3 | $2.56M | Sell |
26,462
-885
| -3% | -$85.5K | 0.13% | 166 |
|
2024
Q2 | $2.35M | Sell |
27,347
-213,994
| -89% | -$18.4M | 0.13% | 156 |
|
2024
Q1 | $19.9M | Sell |
241,341
-74,959
| -24% | -$6.19M | 1.04% | 18 |
|
2023
Q4 | $21.1M | Buy |
316,300
+13,432
| +4% | +$896K | 1.1% | 15 |
|
2023
Q3 | $20.3M | Sell |
302,868
-55,618
| -16% | -$3.74M | 1.14% | 12 |
|
2023
Q2 | $24.3M | Sell |
358,486
-146,718
| -29% | -$9.93M | 1.39% | 5 |
|
2023
Q1 | $27.3M | Buy |
505,204
+15,101
| +3% | +$817K | 1.69% | 3 |
|
2022
Q4 | $29.3M | Buy |
490,103
+7,013
| +1% | +$419K | 1.86% | 3 |
|
2022
Q3 | $21.9M | Sell |
483,090
-97,472
| -17% | -$4.41M | 1.63% | 5 |
|
2022
Q2 | $25.9M | Buy |
580,562
+106,629
| +22% | +$4.75M | 1.8% | 4 |
|
2022
Q1 | $26.8M | Buy |
473,933
+247,311
| +109% | +$14M | 1.66% | 4 |
|
2021
Q4 | $11.8M | Buy |
226,622
+34,743
| +18% | +$1.8M | 0.69% | 50 |
|
2021
Q3 | $11.5M | Buy |
191,879
+10,710
| +6% | +$639K | 0.69% | 41 |
|
2021
Q2 | $11.2M | Sell |
181,169
-4,694
| -3% | -$291K | 0.65% | 50 |
|
2021
Q1 | $12.1M | Buy |
185,863
+22,347
| +14% | +$1.46M | 0.77% | 32 |
|
2020
Q4 | $10.8M | Buy |
163,516
+102,726
| +169% | +$6.76M | 0.77% | 37 |
|
2020
Q3 | $3.14M | Buy |
60,790
+43,829
| +258% | +$2.27M | 0.27% | 136 |
|
2020
Q2 | $836K | Sell |
16,961
-853
| -5% | -$42K | 0.07% | 199 |
|
2020
Q1 | $907K | Buy |
17,814
+12,447
| +232% | +$634K | 0.1% | 175 |
|
2019
Q4 | $296K | Buy |
+5,367
| New | +$296K | 0.02% | 190 |
|
2018
Q1 | – | Sell |
-6,041
| Closed | -$237K | – | 207 |
|
2017
Q4 | $237K | Hold |
6,041
| – | – | 0.02% | 191 |
|
2017
Q3 | $223K | Buy |
+6,041
| New | +$223K | 0.01% | 189 |
|